Biotech | November 08, 2021
Meiji Seika Pharma to build new facility in Bangalore to expand CMO business
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
This unique record was made possible by collating hard copies of the books in a structured manner
This strategic collaboration will enable continued innovation in cancer care
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
Lifebit's accompanying suite of AI-powered end-to-end software solutions provide faster data insights, accelerate drug discovery pipelines, and improve clinical trials success
It is a recombinant nanoparticle protein-based vaccine
Takeda is establishing the capability to manufacture TAK-019 (known outside Japan as NVX-CoV2373) at its facilities in Japan and aims to begin distribution in the early calendar year 2022
Subscribe To Our Newsletter & Stay Updated
